This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, M.
Right arrow Articles by Kobayashi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, M.
Right arrow Articles by Kobayashi, I.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 1999, p. 722-723, Vol. 43, No. 3
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Antimicrobial Susceptibility of Neisseria gonorrhoeae in Fukuoka City, Japan, in the Early 1980s and 1997-1998: Emergence of High-Level Fluoroquinolone Resistance


    LETTER
Top
Letter
References

Resistance to fluoroquinolones in gonococcal isolates has recently become a significant problem in Far East Asia including Japan (2). In the present study, we examined the in vitro antimicrobial susceptibilities of gonococcal isolates from 1997 to 1998 in Fukuoka City, Japan, to various agents, in order to investigate the emergence of high-level fluoroquinolone resistance.

A total of 186 strains of Neisseria gonorrhoeae were isolated from men with urethritis attending a sexually transmitted diseases (STD) clinic in Fukuoka City from March 1997 through March 1998. Of the 186 isolates, 157 were included in this study, while the remaining 29 were from patients known to have received fluoroquinolones or other antibiotics and were excluded. For comparative purposes, antimicrobial susceptibilities of 27 N. gonorrhoeae strains, 14 beta -lactamase producing and 13 not beta -lactamase producing, that were urethral isolates obtained at an STD clinic in the city between 1981 and 1984 were also tested. The MICs for all isolates were determined by an agar dilution technique and twofold dilutions of antibiotic (2). The criterion for high-level ciprofloxacin resistance in N. gonorrhoeae isolates was a MIC of 1 to 16 µg/ml (1). There are no established criteria that define resistance to other fluoroquinolones. Therefore, we set the criteria for high-level resistance as follows: >= 2 µg/ml for norfloxacin, >= 0.5 µg/ml for levofloxacin, >= 0.5 µg/ml for sparfloxacin, and >= 0.25 µg/ml for DU-6859a. The proportions of strains from 1997-1998 with high-level resistance to the five fluoroquinolones were compared with those of strains from 1981 to 1984 by the chi-square test.

Of the 157 strains from 1997-1998, 37 (23.6%) showed high-level resistance to ciprofloxacin (MIC >=  1 µg/ml), while none of the 27 strains from 1981 to 1984 showed high-level resistance to ciprofloxacin. The proportions of the 1997-1998 strains showing high-level resistance to norfloxacin (MIC >=  2 µg/ml), levofloxacin (MIC >=  0.5 µg/ml), sparfloxacin (MIC >=  0.5 µg/ml), and DU-6859a (MIC >=  0.25 µg/ml) were 32.5, 28.7, 21.7, and 8.3%, respectively. On the other hand, none or only one of the 27 isolates from 1981 to 1984 were highly resistant to these fluoroquinolones (Table 1). These differences in prevalence of high-level resistance to the five fluoroquinolones between the strains from 1997-1998 and those from 1981 to 1984 were statistically significant (P < 0.0001). In the present study, the emergence of high-level resistance not only to older fluoroquinolones such as norfloxacin and ciprofloxacin but also to newer ones such as levofloxacin and sparfloxacin was found in N. gonorrhoeae isolates obtained in 1997-1998 in Fukuoka City. However, no significant reductions in the susceptibilities of the 1997-1998 strains to beta -lactams, tetracycline, azithromycin, or spectinomycin were observed.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Distribution of antimicrobial susceptibilities of N. gonorrhoeae isolates to fluoroquinolones


    FOOTNOTES

*  Phone: 81-92-642-5603

Fax: 81-92-642-5618

E-mail: masatosh{at}uro.med.kyushu-u.ac.jp


    REFERENCES
Top
Letter
References

1. Handsfield, H. H., and W. L. Whittington. 1996. Antibiotic-resistant Neisseria gonorrhoeae: the calm before another storm? Ann. Intern. Med. 125:507-509[Free Full Text].
2. Tanaka, M., T. Matsumoto, I. Kobayashi, U. Uchino, and J. Kumazawa. 1995. Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan. Antimicrob. Agents Chemother. 39:2367-2370[Abstract].
Masatoshi Tanaka*
Seiji Naito
Department of Urology
Faculty of Medicine
Kyushu University
3-1-1, Maidashi
Higashi-ku, Fukuoka 812-8582
Japan
Hiroshi Nakayama
Nakayama Urologic Clinic
Fukuoka, Japan
Intetsu Kobayashi
Division of Chemotherapy
Mitsubishi kagaku BCL
Tokyo, Japan


Antimicrobial Agents and Chemotherapy, March 1999, p. 722-723, Vol. 43, No. 3
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, M.
Right arrow Articles by Kobayashi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, M.
Right arrow Articles by Kobayashi, I.